{
  "id": 20247398,
  "title": "Johnson & Johnson looking to buy Ollin Biosciences for up to US$3.4bil",
  "url": "https://urgent.news/2026/11/16/johnson-johnson-looking-to-buy-ollin-biosciences-for-up-to-us-3-4bil",
  "topic": "world",
  "section": "World",
  "published": "2026-11-16T00:42:00.000Z",
  "source": {
    "name": "New Straits Times",
    "slug": "new-straits-times",
    "url": "https://www.nst.com.my/business/corporate/2026/11/1578636/johnson-johnson-looking-buy-ollin-biosciences-us34bil"
  },
  "original_language": "en",
  "account": null,
  "summary": "NEW YORK: Johnson & Johnson is poised to buy privately held eye disease drug developer Ollin Biosciences for up to US$3.4 billion, the Financial Times reported on Sunday, citing people familiar with the matter.",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}